Aptose Biosciences
Stock Forecast, Prediction & Price Target
Aptose Biosciences Financial Estimates
Aptose Biosciences Revenue Estimates
Aptose Biosciences EBITDA Estimates
Aptose Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CA$0 N/A | CA$0 0% | CA$0 0% | Avg: CA$524.28K Low: CA$524.28K High: CA$524.28K avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. -100% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% |
Net Income
% change YoY
| CA$-65.26M N/A | CA$-41.05M 37.09% | CA$-51.20M -24.73% | Avg: CA$-14.86M Low: CA$-19.31M High: CA$-10.42M avg. 70.96% | Avg: CA$-5.06M Low: CA$-5.06M High: CA$-5.06M avg. 65.96% | Avg: CA$-3.74M Low: CA$-3.74M High: CA$-3.74M avg. 26.02% | Avg: CA$-2.42M Low: CA$-2.42M High: CA$-2.42M avg. 35.18% |
EBITDA
% change YoY
| CA$-64.82M N/A | CA$-42.06M 35.10% | CA$-52.26M -24.25% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 100% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% |
EPS
% change YoY
| -$10.99 N/A | -$0.44 95.99% | -$7.58 -1622.72% | Avg: -$2.2 Low: -$2.86 High: -$1.54 avg. 70.95% | Avg: -$0.75 Low: -$0.75 High: -$0.75 avg. 65.96% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 26.02% | Avg: -$0.36 Low: -$0.36 High: -$0.36 avg. 35.18% |
Operating Expenses
% change YoY
| CA$65.44M N/A | CA$42.60M -34.90% | CA$52.35M 22.89% | Avg: CA$0 Low: CA$0 High: CA$0 avg. -100% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% |
FAQ
What is Aptose Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 49.53% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -19.31M, average is -14.86M and high is -10.42M.
What is Aptose Biosciences stock revenue growth forecast?
We have gathered data from 3 analysts. Their low revenue estimate is CA$524.28K, average is CA$524.28K and high is CA$524.28K.
What is Aptose Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 49.53% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.86, average is -$2.2 and high is CA$-1.54.